MetLife, Inc.

MET · NYSE · USD

PoliticiansInstitutionalInsiders

Current holders

Politician	Disclosed
Donald Trump R · EXECUTIVE	net −$589K – −$107K 12 disclosures · 3 bought / 9 sold · last Jun 15, 2026
John Hoeven R · SENATE · ND	$100K – $200K $223K – $446K today 2 filings · last Mar 22, 2019
Thad Cochran R · HOUSE · MS	−$5K – $135K $4K – $286K today 4 filings · last May 26, 2017
Bill Flores R · HOUSE · TX	$15K – $50K $29K – $97K today 1 filing · last Jul 15, 2019
David E. Price D · HOUSE · NC	$4K – $60K $9K – $128K today 4 filings · last Aug 3, 2016
Michael G. Fitzpatrick R · HOUSE · PA	$1K – $15K $2K – $31K today 1 filing · last Jan 27, 2015
Alan Armstrong R · SENATE · OK	$1K – $15K $1K – $22K today 1 filing · last Mar 27, 2026
Gary J. Palmer R · HOUSE · AL	$1K – $15K $2K – $34K today 1 filing · last Jul 12, 2018
Bob Corker R · HOUSE · TN	−$14K – $14K −$28K – $25K today 2 filings · last May 20, 2014
Sheldon Whitehouse D · SENATE · RI	−$28K – $28K −$36K – $69K today 4 filings · last Nov 19, 2024

Recent transactions

Trades from Jan 22, 2025 – Jun 15, 2026

Politician	Type	Filed after	Amount
Donald Trump R · EXECUTIVE	Buy	68 days Jun 15, 2026 → Aug 22, 2026	≥$50K
Alan Armstrong R · SENATE · OK	Buy	116 days Mar 27, 2026 → Jul 21, 2026	≥$1K
Ro Khanna D · HOUSE · CA-17	Buy	34 days Jun 2, 2026 → Jul 6, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	51 days May 11, 2026 → Jul 1, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	49 days Mar 25, 2026 → May 13, 2026	≥$15K
Donald Trump R · EXECUTIVE	Sell	56 days Mar 18, 2026 → May 13, 2026	≥$1K
Donald Trump R · EXECUTIVE	Buy	57 days Mar 17, 2026 → May 13, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	57 days Mar 17, 2026 → May 13, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	70 days Mar 4, 2026 → May 13, 2026	≥$1K
Donald Trump R · EXECUTIVE	Sell	79 days Feb 23, 2026 → May 13, 2026	≥$1K

Congressional trading data provided by QuiverQuant

Institutional

Investors holding

1,516

13F shares

489.1M

Total invested

$41.4B

Ownership

75.0%

New positions

178

Closed positions

107

Increased positions

735

Reduced positions

498

Put/Call ratio

1.10

Holder	Reported	Shares	Value	Δ Qtr
BLACKROCK, INC.	8/7/2026	51.8M	$4.4B	+0.71%
DODGE & COX	8/13/2026	48.4M	$4.1B	−5.25%
VANGUARD CAPITAL MANAGEMENT LLC	8/13/2026	35.5M	$3.0B	−1.04%
VANGUARD PORTFOLIO MANAGEMENT LLC	8/13/2026	30M	$2.5B	−2.54%
STATE STREET CORP	9/22/2026	25.3M	$2.1B	+0.46%
PRICE T ROWE ASSOCIATES INC /MD/	8/14/2026	21.3M	$1.8B	−6.59%
GEODE CAPITAL MANAGEMENT, LLC	8/12/2026	13.3M	$1.1B	+0.50%
MORGAN STANLEY	8/13/2026	12.5M	$1.1B	+12.69%
PZENA INVESTMENT MANAGEMENT LLC	8/7/2026	11.1M	$941.8M	−1.53%
DIMENSIONAL FUND ADVISORS LP	8/11/2026	7.2M	$608.5M	+0.95%
INVESCO LTD.	8/14/2026	6.9M	$586.3M	+0.15%
NORGES BANK	8/12/2026	6.8M	$577.0M	—
GOLDMAN SACHS GROUP INC	8/14/2026	6.6M	$560.7M	+6.73%
NORTHERN TRUST CORP	8/13/2026	6.3M	$533.3M	−0.55%
UBS ASSET MANAGEMENT AMERICAS INC	8/13/2026	6M	$509.9M	+5.92%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	8/13/2026	5.8M	$491.5M	+87.46%
CLEARBRIDGE INVESTMENTS, LLC	8/13/2026	5.6M	$477.3M	+9.54%
BANK OF AMERICA CORP /DE/	8/14/2026	5.4M	$455.4M	−2.13%
NORDEA INVESTMENT MANAGEMENT AB	8/5/2026	5M	$429.0M	+5.12%
JPMORGAN CHASE & CO	8/12/2026	4.1M	$352.6M	+19.64%
AQR CAPITAL MANAGEMENT LLC	8/14/2026	4.1M	$348.8M	+13.08%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	8/14/2026	3.9M	$328.5M	+0.79%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.	8/14/2026	3.9M	$328.5M	—
LEGAL & GENERAL GROUP PLC	8/14/2026	3.9M	$326.9M	−7.18%
AMUNDI	8/11/2026	3.6M	$306.9M	+41.71%

Insider transactions

Insider	Type	Transacted	Price	Date
Mumenthaler Christian Stephane	A-AWARD	21	$95.50	Sep 8
Hay Laura J	A-AWARD	39	$95.50	Sep 8
Mckenzie Diana	A-AWARD	157	$95.50	Sep 8
Tadros Ramy	A-AWARD	115	$95.50	Sep 8
Johnson Jeh C.	A-AWARD	59	$95.50	Sep 8
Harris Carla A	A-AWARD	42	$95.50	Sep 8
Glaser Daniel S	A-AWARD	10	$95.50	Sep 8
Hubbard Robert Glenn	A-AWARD	618	$95.50	Sep 8
Kennard William E	A-AWARD	294	$95.50	Sep 8
Pappas Bill	F-INKIND	4K	$95.17	Aug 31

Analyst consensus

Buy33 analysts

Bearish · 0 · Hold · 7 · Bullish · 26

Earnings history

	EPS	Estimate
Q3 2024	$1.95	$2.17	Miss
Q4 2024	$2.08	$2.11	Miss
Q1 2025	$1.96	$2.00	Miss
Q2 2025	$2.02	$2.15	Miss
Q3 2025	$2.34	$2.31	Beat
Q4 2025	$2.58	$2.34	Beat
Q1 2026	$2.42	$2.27	Beat
Q2 2026	$2.43	$2.30	Beat

Peers

Company overview

IPO dateApr 5, 2000

CEOMichel Abbas Khalaf

Employees46,000

SectorFinancial Services

IndustryInsurance - Life

CountryUS

ExchangeNew York Stock Exchange

Websitewww.metlife.com

MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.